Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Cancer treatments often cause skin, nail, and hair problems.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Septin4 helps kill colon cancer cells by working with the protein BAX.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

A cancer patient's hair became permanently curly after treatment with nivolumab.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Overexpression of HDGF in melanocytes does not cause cancer.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.